Lightrock

📣 Lightrock has participated in a $258m funding round for Mainspring Energy to support the company's continued growth and growing impact!   🧲 Lightrock partnered with this designer and manufacturer of innovative fuel-flexible linear generators back in 2022. These generators use magnets to create motion, which is directly converted into electricity. They can seamlessly switch between various fuel qualities and types, including renewables like biogas, green hydrogen, and green ammonia.   🤝 Lightrock is pleased to be backing Mainspring alongside General Catalyst, the round leader, and other existing investors including LGT Private Banking, Khosla Ventures, and Bill Gates. This round also included Amazon’s Climate Pledge Fund, Temasek, M&G plc, and DCVC, among others. 🎉 Congratulations to Shannon Miller and the wider Mainspring team for this latest milestone!   🔗 For more information, check out the Bloomberg linked in the comments.   Lightrock team: Kevin Bone, Oliver Sweeney, Sophie Lara N.

🌟 Lightrock has featured in Morningstar’s EMEA & Asia Prospects List for its Global Small-Cap strategy! 📋 The list spotlights 25 out of over 1,300 actively managed equity, fixed-income, multi-asset, and alternative strategies across Europe and Asia. The Morningstar Prospects are considered for their unique strategies or processes, an existing strategy with new management, or a new strategy run by managers with long records elsewhere. 👏 We’re extremely pleased to be included as a new Morningstar Prospect, and are proud of the recognition given to our experienced Global Small-Cap team – Maarten Vankan, Chris Kaashoek, Michiel van Dijk, CFA and Luuk Jagtenberg. 👇 To read the Morningstar report, please click on the link in the comments.

📣 Lightrock has participated in a $200m funding round for CMR Surgical to accelerate international expansion and innovation in surgical robotics.    🦾 Lightrock partnered with the global medical devices company back in 2016. With Versius®, CMR’s next-generation surgical robot, the company seeks to improve the accessibility and affordability of surgical care with both patients and medical staff in mind. Versius® is the second-most utilised soft tissue surgical robot in the world and has been used in more than 30,000 surgical cases around the world across specialties including colorectal, general, gynaecology, and urology surgeries.   🏥 The fundraising was supported by all the company’s existing major shareholders including Lightrock, as well as a debt investment from Trinity Capital as a new investor.    🔗 For more information on this exciting milestone, check out the press release linked in the comments.

📢 We are proud to share that Lightrock's Global Small-Cap Fund has been awarded the Towards Sustainability label (CLA). This recognition underscores our commitment to integrating social, environmental, and governance (ESG) factors into our public market investment decision-making processes. 💚 The Towards Sustainability label ensures adherence to criteria for sustainable and socially responsible investments. This accolade complements our B Corp certification and emphasises our dedication to continuous improvement in sustainability practices. 🔗 Learn more about the Towards Sustainability Label and explore our strategy via the links the in comments. 

🇳🇱 Head of Investor Relations Dr. Katharina Sommerrock and Martin Karschkes will be at Phenix Capital Group's Impact Summit Europe in Amsterdam, the Netherlands! 💼 This leading impact investing conference is designed to bring together the industry's thought leaders and practitioners for its 11th edition. It aims to provide the necessary tools, knowledge and networking opportunities to support the pursuit of positive impact and returns.   📨 If you are attending the event, please get in touch via the conference platform or via LinkedIn DM.   🔗 For more information on the agenda or to register, click on the link in the comments.

💵 Congratulations to Lightrock-backed AMPIN Energy Transition for its recent $50m funding round with Siemens Financial Services! 🔋 Lightrock partnered with this leading renewable energy transition company in 2020. Its renewable energy assets include solar, wind, and storage, providing green power to Utility and Commercial & Industrial customers in sectors such as pharmaceuticals, automobiles, cement, FMCG, and government bodies. ⚡ AMPIN’s total portfolio is already 5GWp across 22 states throughout the country. Lightrock looks forward to collaborating with Siemens on this journey as AMPIN scales its role in India’s energy transition. 🔗 For more information on the investment, check out the link in the comments.

📣 We're very excited to share that Lightrock co-led AMBOSS’s funding round! 🏥 AMBOSS is a medical learning platform for students and practicing professionals to support efficient patient care. Through its question bank and interactive library, aspiring medics can access the knowledge they need for general study and exam preparation, whilst professionals can use AMBOSS’s evidence-based recommendations to enhance their clinical decisions. Today, more than 1 million healthcare professionals in over 180 countries use AMBOSS to support their duty of care. 🤝 Lightrock invested alongside M&G plc and KIRKBI A/S. We’re pleased to be investing in AMBOSS alongside existing investors Partech, Wellington Management, Quadrille Capital, and Cherry Ventures, as well as new investors Maj Invest, Burda Principal Investments, and Project A. ⬇️ For more information, check out the Bloomberg article by Arno Schuetze and Christina Kyriasoglou linked in the comments. Lightrock team: Christopher Steinau, Martin Karschkes, Rory Glover, Jorrit de Haan

📰 Lightrock’s Head of Fund Finance Alexander Moore has featured in The Drawdown! 🎨 The article explores the valuations process as an art form, highlighting the creativity and skill involved in presenting a strong justification for the numbers that satisfies both the GP and the auditors. 🔢 Alex explains the key factors that ensure a robust valuation process, how his work supports the investment committee, and the additional considerations required to appropriately value impact investments. 👇 Check out Matthias Plötz’s article, linked in the comments.

📺 This week, CMR Surgical featured on BBC’s The One Show! 🦾 The segment covered how Huddersfield Royal Infirmary has dramatically improved its waiting times since introducing new medical technologies, including Versius®, the second-most used soft-tissue surgical robot on the market. Versius® can be used in general surgeries and for range of specialities, such as urology, colorectal, and gynaecology. This has enabled the hospital to operate on 30% more patients, and has helped to bring the number of patients waiting over 12 months for an appointment down from ~4,000 to less than 20 in 3 years. 🏥 Lightrock partnered with the global medical devices company in 2016. By developing minimally invasive surgical equipment, CMR Surgical seeks to improve the accessibility and affordability of surgical care with both patients and medical staff in mind. 🎞️ For more insights into how CMR Surgical is positively impacting lives, check out the clip linked in the comments.

🇧🇧 Lightrock and South Pole teamed up last week to support the Sustainable Energy for All (SEforALL) Global Forum last week, an important gathering for stakeholders in the energy access ecosystem. 🗣️ Our Managing Partner & CEO Pal Erik Sjatil contributed to the agenda, discussing solutions to energy transition challenges, while Partner Ademidun (Demi) Edosomwan served on a panel of judges for a Shark Tank competition aimed at energy access founders. 🤝 Alongside our portfolio company South Pole, we also thoroughly enjoyed hosting new friends and colleagues at a special networking reception on the conference’s first day. 🙏 We want to extend our thanks to the entire SEforALL production team and leadership for their partnership across this event and their critical work aimed at achieving UN SDG7. 👇 Learn more about the forum and its impacts by checking out the link in the comments.